Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1995 1
2004 1
2010 2
2011 2
2012 1
2013 1
2014 2
2015 1
2016 1
2018 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model.
von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Côté AM, Douglas MJ, Gruslin A, Hutcheon JA, Joseph KS, Kyle PM, Lee T, Loughna P, Menzies JM, Merialdi M, Millman AL, Moore MP, Moutquin JM, Ouellet AB, Smith GN, Walker JJ, Walley KR, Walters BN, Widmer M, Lee SK, Russell JA, Magee LA; PIERS Study Group. von Dadelszen P, et al. Lancet. 2011 Jan 15;377(9761):219-27. doi: 10.1016/S0140-6736(10)61351-7. Epub 2010 Dec 23. Lancet. 2011. PMID: 21185591 Free article. Clinical Trial.
Machine learning-enabled maternal risk assessment for women with pre-eclampsia (the PIERS-ML model): a modelling study.
Montgomery-Csobán T, Kavanagh K, Murray P, Robertson C, Barry SJE, Vivian Ukah U, Payne BA, Nicolaides KH, Syngelaki A, Ionescu O, Akolekar R, Hutcheon JA, Magee LA, von Dadelszen P; PIERS Consortium. Montgomery-Csobán T, et al. Lancet Digit Health. 2024 Apr;6(4):e238-e250. doi: 10.1016/S2589-7500(23)00267-4. Lancet Digit Health. 2024. PMID: 38519152 Free PMC article.
An international trial of antioxidants in the prevention of preeclampsia (INTAPP).
Xu H, Perez-Cuevas R, Xiong X, Reyes H, Roy C, Julien P, Smith G, von Dadelszen P, Leduc L, Audibert F, Moutquin JM, Piedboeuf B, Shatenstein B, Parra-Cabrera S, Choquette P, Winsor S, Wood S, Benjamin A, Walker M, Helewa M, Dubé J, Tawagi G, Seaward G, Ohlsson A, Magee LA, Olatunbosun F, Gratton R, Shear R, Demianczuk N, Collet JP, Wei S, Fraser WD; INTAPP study group. Xu H, et al. Among authors: tawagi g. Am J Obstet Gynecol. 2010 Mar;202(3):239.e1-239.e10. doi: 10.1016/j.ajog.2010.01.050. Am J Obstet Gynecol. 2010. PMID: 20207239 Clinical Trial.
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
Knip M, Åkerblom HK, Becker D, Dosch HM, Dupre J, Fraser W, Howard N, Ilonen J, Krischer JP, Kordonouri O, Lawson ML, Palmer JP, Savilahti E, Vaarala O, Virtanen SM; TRIGR Study Group. Knip M, et al. JAMA. 2014 Jun 11;311(22):2279-87. doi: 10.1001/jama.2014.5610. JAMA. 2014. PMID: 24915259 Free PMC article. Clinical Trial.
The impact of increasing obesity class on obstetrical outcomes.
El-Chaar D, Finkelstein SA, Tu X, Fell DB, Gaudet L, Sylvain J, Tawagi G, Wu Wen S, Walker M. El-Chaar D, et al. Among authors: tawagi g. J Obstet Gynaecol Can. 2013 Mar;35(3):224-233. doi: 10.1016/S1701-2163(15)30994-4. J Obstet Gynaecol Can. 2013. PMID: 23470110
PIERS proteinuria: relationship with adverse maternal and perinatal outcome.
Payne B, Magee LA, Côté AM, Hutcheon JA, Li J, Kyle PM, Menzies JM, Peter Moore M, Parker C, Pullar B, von Dadelszen P, Walters BN; PIERS Study Group (Appendix); von Dadelszen P, Magee LA, Douglas MJ, Walley KR, Russell JA, Lee SK, Gruslin A, Smith GN, Côté AM, Moutquin JM, Brown MA, Davis G, Walters BN, Sass N, Duan T, Zhou J, Mahajan S, Noovao A, McCowan LA, Kyle P, Moore MP, Bhutta SZ, Bhutta ZA, Hall, Steyn DW, Broughton Pipkin F, Loughna P, Robson S, de Swiet M, Walker JJ, Grobman WA, Lindheimer MD, Roberts JM, Mark Ansermino J, Benton S, Cundiff G, Hugo D, Joseph KS, Lalji S, Li J, Lott P, Ouellet AB, Shaw D, Keith Still D, Tawagi G, Wagner B, Biryabarema C, Mirembe F, Nakimuli A, Tsigas E, Merialdi M, Widmer M. Payne B, et al. Among authors: tawagi g. J Obstet Gynaecol Can. 2011 Jun;33(6):588-597. doi: 10.1016/S1701-2163(16)34907-6. J Obstet Gynaecol Can. 2011. PMID: 21846448
Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial.
Writing Group for the TRIGR Study Group; Knip M, Åkerblom HK, Al Taji E, Becker D, Bruining J, Castano L, Danne T, de Beaufort C, Dosch HM, Dupre J, Fraser WD, Howard N, Ilonen J, Konrad D, Kordonouri O, Krischer JP, Lawson ML, Ludvigsson J, Madacsy L, Mahon JL, Ormisson A, Palmer JP, Pozzilli P, Savilahti E, Serrano-Rios M, Songini M, Taback S, Vaarala O, White NH, Virtanen SM, Wasikowa R. Writing Group for the TRIGR Study Group, et al. JAMA. 2018 Jan 2;319(1):38-48. doi: 10.1001/jama.2017.19826. JAMA. 2018. PMID: 29297078 Free PMC article. Clinical Trial.
14 results